Provided by Tiger Trade Technology Pte. Ltd.

Cannabis Concept

243.37
+0.21790.09%
Number of Gainers:4
Number of Losers:11
Number of Flat:1
PE:- -
High:246.07
Open:243.13
Low:241.38
Close:243.15
Volume:28.37M
Turnover:244.31M
Market Cap:58.38B
Float Cap:51.37B

Loading ...

Table: Aurora Corp Aug Rev Nt$950.6m vs Nt$917.5m

Dow Jones
·
23 mins ago

AIM ImmunoTech Advances Phase 2 Duripanc Trial of Ampligen Plus AstraZeneca’s Imfinzi in Pancreatic Cancer

Reuters
·
Yesterday

Leerink Partners Initiates Coverage on Harrow With Outperform Rating, $45 Price Target

MT Newswires Live
·
Yesterday

Press Release: Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business

Dow Jones
·
Yesterday

Press Release: Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business

Dow Jones
·
Yesterday

Broncos Country, This One’s for You: Breckenridge Distillery Kicks Off Another Season with the Denver Broncos and a Limited-Edition Whiskey Collection Honoring “The Drive”

GlobeNewswire
·
Yesterday

Dr. Reddy's Laboratories Slides Wednesday, Still Outperforms Market

Dow Jones
·
Yesterday

Teva initiated with an Outperform at Leerink

TIPRANKS
·
Yesterday

Harrow initiated with an Outperform at Leerink

TIPRANKS
·
Yesterday

SNDL Sets October 15 Virtual Meeting and Seeks Approval for Share Consolidation

TIPRANKS
·
Yesterday

SNDL Sets Virtual Annual and Special Shareholder Meeting, Share Consolidation Vote on Agenda

Reuters
·
Yesterday

SNDL Announces Annual and Special Shareholder Meeting

Reuters
·
Yesterday

Cannabis Poland Raises Capital Through New Share Issue and Warrant Allocation to CPAR

TIPRANKS
·
Yesterday

Curaleaf Challenges Aurora Criticism, Defends Premium Takeover Offer

TIPRANKS
·
Sep 08

Curaleaf issues fact sheet to address ‘misleading’ statements from Aurora

TIPRANKS
·
Sep 08

Veru Plans Phase 2 Trial of Oral Sabizabulin in Daraxonrasib-Resistant Metastatic Pancreatic Cancer

Reuters
·
Sep 08

Veru - to Advance Oral Sabizabulin for Metastatic Pancreatic Cancer Resistant to Daraxonrasib

THOMSON REUTERS
·
Sep 08

Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ Rasonque™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial

THOMSON REUTERS
·
Sep 08

Green360 Technologies Updates Registered Office to Perth CBD

TIPRANKS
·
Sep 08

1414 Degrees Seeks Partners for Aurora Grid-Scale Solar and Battery Project

TIPRANKS
·
Sep 08